METI / Merge Tech Inc - SEC फाइलिंग, वार्षिक रिपोर्ट, प्रॉक्सी स्टेटमेंट

मर्ज टेक इंक
US ˙ OTC
यह प्रतीक अब सक्रिय नहीं है

मूलभूत आँकड़े
CIK 944765
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Merge Tech Inc
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
October 26, 2015 SC 13D/A

METI / Merge Tech Inc / Merrick Venture Management Holdings, Llc - MERRICK VENTURE MANAGEMENT HOLDINGS, LLC SC 13D A NO 11 10-13-2015 (MERGE HEALTHCARE INCORPORATED) Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 11) Merge Healthcare Incorporated (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Secur

October 23, 2015 15-12B

Merge Tech CERTIFICATION AND NOTICE OF TERMINATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-33006 MERGE HEALTHCARE INCORPORATED (Exact name of registrant as specifi

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 3

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 2

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 6

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 4

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 3

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 2

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 4

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech AM

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 4

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 3

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 21, 2015 POS AM

Merge Tech POST-EFFECTIVE AMENDMENT NO. 2

As filed with the Securities and Exchange Commission on October 21, 2015 Registration No.

October 15, 2015 SC 13D/A

METI / Merge Tech Inc / GUGGENHEIM CAPITAL LLC Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Merge Healthcare Incorporated (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 589499102 (CUSIP Number) Robert Saperstein 330 Madison Avenue New York, NY 10017 (212) 901-9402 (Name, Address and Telephone Number of Person Authorized to

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on October 14, 2015 Registration No.

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 2

As filed with the Securities and Exchange Commission on October 14, 2015 Registration No.

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 2

As filed with the Securities and Exchange Commission on October 14, 2015 Registration No.

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on October 14, 2015 Registration No.

October 14, 2015 EX-2.1

AGREEMENT AND PLAN OF MERGER INTERNATIONAL BUSINESS MACHINES CORPORATION DATONG ACQUISITION CORP. MERGE HEALTHCARE INCORPORATED Dated as of August 6, 2015 TABLE OF CONTENTS

EX-2.1 2 ex2-1.htm AGREEMENT AND PLAN OF MERGER Exhibit 2.1 AGREEMENT AND PLAN OF MERGER Among INTERNATIONAL BUSINESS MACHINES CORPORATION DATONG ACQUISITION CORP. and MERGE HEALTHCARE INCORPORATED Dated as of August 6, 2015 TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 2 SECTION 1.02. Closing 2 SECTION 1.03. Effective Time of the Merger 2 SECTION 1.04. Effects of the Merger

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on October 14, 2015 Registration No.

October 14, 2015 EX-3.2

MERGE HEALTHCARE INCORPORATED ARTICLE I Meetings of Stockholders; Stockholders’ Consent in Lieu of Meeting

EX-3.2 4 ex3-2.htm AMENDED AND RESTATED BYLAWS Exhibit 3.2 BY-LAWS OF MERGE HEALTHCARE INCORPORATED ARTICLE I Meetings of Stockholders; Stockholders’ Consent in Lieu of Meeting SECTION 1.01. Annual Meeting. The annual meeting of the stockholders for the election of directors, and for the transaction of such other business as may properly come before the meeting, shall be held at such place, date a

October 14, 2015 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

8-K 1 form8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2015 (October 13, 2015) MERGE HEALTHCARE INCORPORATED (Exact Name of Registrant as Specified in Charter) Delaware 001-33006 39-1600938 (Sta

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on October 14, 2015 Registration No.

October 14, 2015 S-8 POS

Merge Tech POST EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on October 14, 2015 Registration No.

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

S-8 POS 1 s-8pos.htm POST-EFFECTIVE AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on October 14, 2015 Registration No. 333-107997 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION NO. 333-107997 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Merge Healthcare Incorporated (Exact name of regis

October 14, 2015 EX-3.1

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION MERGE HEALTHCARE INCORPORATED ARTICLE I

EX-3.1 3 ex3-1.htm AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MERGE HEALTHCARE INCORPORATED ARTICLE I The name of the corporation (hereinafter called the “Corporation”) is Merge Healthcare Incorporated. ARTICLE II The address, including street, number, city, and county, of the registered office of the Corporation in the State

October 14, 2015 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2015 (October 13, 2015) MERGE HEALTHCARE INCORPORATED (Exact Name of Registrant as Specified in Charter) Delaware 001-33006 39-1600938 (State of Incorporation) (Commission

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 2

As filed with the Securities and Exchange Commission on October 14, 2015 Registration No.

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on October 14, 2015 Registration No.

October 14, 2015 S-8 POS

Merge Tech POST-EFFECTIVE AMENDMENT NO. 1

S-8 POS 1 s-8pos.htm POST-EFFECTIVE AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on October 14, 2015 Registration No. 333-196947 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION NO. 333-196947 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Merge Healthcare Incorporated (Exact name of regis

October 5, 2015 DEFA14A

Merge Tech MERGE HEALTHCARE INC DEFA 14A 10-5-2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

September 11, 2015 DEFM14A

Merge Tech DEFM14A

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi

September 1, 2015 PREM14A

Merge Tech MERGE HEALTHCARE INCORPORATED PREM 14A 8-31-2015

PREM14A 1 formprem14a.htm MERGE HEALTHCARE INCORPORATED PREM 14A 8-31-2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant T Filed by a Party other than the Registrant ☐ Check the appropriate box: T Preliminary Proxy Statement ☐ Confidential, for Use of the

August 14, 2015 DEFA14A

Merge Tech MERGE HEALTHCARE INC DEFA 14A 8-14-2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide

August 12, 2015 8-K

Financial Statements and Exhibits, Other Events

8-K 1 form8k.htm MERGE HEALTHCARE INC. 8-K 8-6-2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 12, 2015 (August 6, 2015) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 0

August 12, 2015 DEFA14A

Merge Tech MERGE HEALTHCARE INC DEFA 14A 8-12-2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide

August 12, 2015 EX-99.1

EX-99.1

Exhibit 99.1 Watson to Gain Ability to ?See? with Planned $1B Acquisition of Merge Healthcare Deal Brings Watson Technology Together with Leader in Medical Images Armonk, NY and CHICAGO - [August 6, 2015]: IBM (NYSE: IBM) today announced that Watson will gain the ability to ?see? by bringing together Watson?s advanced image analytics and cognitive capabilities with data and images obtained from Me

August 12, 2015 EX-10.2

CONTINGENT TERMINATION AGREEMENT

Exhibit 10.2 CONTINGENT TERMINATION AGREEMENT This Contingent Termination Agreement (this ? Agreement?) is made as of August 6, 2015, by and among Merge Healthcare Incorporated (the ? Company?), Merge eMed, Inc., Cedara Software Corp., Cedara Software (USA) Limited, Merge Technologies Holdings Co., eFilm Medical Inc., Merge Cedara ExchangeCo Limited, Cedara Software Limited (collectively with the

August 12, 2015 EX-10.1

August 6, 2015

EX-10.1 3 ex101.htm EXHIBIT 10.1 Exhibit 10.1 August 6, 2015 Merrick Ventures, LLC 320 N. Orleans Street, 10th Floor Chicago, IL 60654 Re: Consulting Agreement Ladies and Gentlemen: Reference is made to that certain Amended and Restated Consulting Agreement (as amended, the “Consulting Agreement”), dated as of May 29, 2015, by and between Merge Healthcare Incorporated, a Delaware corporation (the

August 12, 2015 EX-2.1

AGREEMENT AND PLAN OF MERGER INTERNATIONAL BUSINESS MACHINES CORPORATION DATONG ACQUISITION CORP. MERGE HEALTHCARE INCORPORATED Dated as of August 6, 2015 TABLE OF CONTENTS

EX-2.1 2 ex21.htm EXHIBIT 2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER Among INTERNATIONAL BUSINESS MACHINES CORPORATION DATONG ACQUISITION CORP. and MERGE HEALTHCARE INCORPORATED Dated as of August 6, 2015 TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 2 SECTION 1.02. Closing 2 SECTION 1.03. Effective Time of the Merger 2 SECTION 1.04. Effects of the Merger 2 SECTION 1.05. C

August 12, 2015 EX-99.1

Watson to Gain Ability to “See” with Planned $1B Acquisition of Merge Healthcare Deal Brings Watson Technology Together with Leader in Medical Images

EX-99.1 5 ex991.htm EXHIBIT 99.1 Exhibit 99.1 Watson to Gain Ability to “See” with Planned $1B Acquisition of Merge Healthcare Deal Brings Watson Technology Together with Leader in Medical Images Armonk, NY and CHICAGO - [August 6, 2015]: IBM (NYSE: IBM) today announced that Watson will gain the ability to “see” by bringing together Watson’s advanced image analytics and cognitive capabilities with

August 12, 2015 DEFA14A

Merge Tech MERGE HEALTHCARE INC. 8-K 8-6-2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 12, 2015 (August 6, 2015) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001?33006 39-1600938 (State of incorporation) (Commission File Number) (I.

August 12, 2015 EX-10.1

August 6, 2015

EX-10.1 3 ex101.htm EXHIBIT 10.1 Exhibit 10.1 August 6, 2015 Merrick Ventures, LLC 320 N. Orleans Street, 10th Floor Chicago, IL 60654 Re: Consulting Agreement Ladies and Gentlemen: Reference is made to that certain Amended and Restated Consulting Agreement (as amended, the “Consulting Agreement”), dated as of May 29, 2015, by and between Merge Healthcare Incorporated, a Delaware corporation (the

August 12, 2015 EX-2.1

AGREEMENT AND PLAN OF MERGER INTERNATIONAL BUSINESS MACHINES CORPORATION DATONG ACQUISITION CORP. MERGE HEALTHCARE INCORPORATED Dated as of August 6, 2015 TABLE OF CONTENTS

EX-2.1 2 ex21.htm EXHIBIT 2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER Among INTERNATIONAL BUSINESS MACHINES CORPORATION DATONG ACQUISITION CORP. and MERGE HEALTHCARE INCORPORATED Dated as of August 6, 2015 TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 2 SECTION 1.02. Closing 2 SECTION 1.03. Effective Time of the Merger 2 SECTION 1.04. Effects of the Merger 2 SECTION 1.05. C

August 12, 2015 EX-10.2

CONTINGENT TERMINATION AGREEMENT

EX-10.2 4 ex102.htm EXHIBIT 10.2 Exhibit 10.2 CONTINGENT TERMINATION AGREEMENT This Contingent Termination Agreement (this “Agreement”) is made as of August 6, 2015, by and among Merge Healthcare Incorporated (the “Company”), Merge eMed, Inc., Cedara Software Corp., Cedara Software (USA) Limited, Merge Technologies Holdings Co., eFilm Medical Inc., Merge Cedara ExchangeCo Limited, Cedara Software

August 6, 2015 DEFA14A

Merge Tech MERGE HEALTHCARE INC DEFA 14A 8-6-2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide

July 28, 2015 10-Q

Merge Tech MERGE HEALTHCARE INC 10-Q 6-30-2015 (Quarterly Report)

10-Q 1 form10q.htm MERGE HEALTHCARE INC 10-Q 6-30-2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Com

July 23, 2015 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 form8k.htm MERGE HEALTHCARE INCORPORATED 8-K 7-23-2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 23, 2015 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 3

July 23, 2015 EX-99.1

MERGE REPORTS SECOND QUARTER FINANCIAL RESULTS GAAP sales growth of 22% year-over-year, GAAP EPS of $0.01 per share, adjusted EPS of $0.09 per share

EX-99.1 2 ex991.htm EXHIBIT 99.1 Exhibit 99.1 News Release Media Contact: Michael Klozotsky Vice President, Corporate Marketing 312.946.2535 [email protected] MERGE REPORTS SECOND QUARTER FINANCIAL RESULTS GAAP sales growth of 22% year-over-year, GAAP EPS of $0.01 per share, adjusted EPS of $0.09 per share Chicago, IL (July 23, 2015) – Merge Healthcare Incorporated (NASDAQ: MRGE), a lead

July 2, 2015 SC 13D/A

METI / Merge Tech Inc / GUGGENHEIM CAPITAL LLC Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Merge Healthcare Incorporated (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 589499102 (CUSIP Number) Robert Saperstein 330 Madison Avenue New York, NY 10017 (212) 901-9402 (Name, Address and Telephone Number of Person Authorized to

June 19, 2015 EX-24

MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS

Exhibit 24 MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS KNOWN ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints JUSTIN C.

June 19, 2015 S-8

Merge Tech MERGE HEALTHCARE INCORPORATED S-8 6-19-2015

S-8 1 forms8.htm MERGE HEALTHCARE INCORPORATED S-8 6-19-2015 As filed with the Securities and Exchange Commission on June 19, 2015. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 Registration Statement Under The Securities Act of 1933 MERGE HEALTHCARE INCORPORATED (Exact name of Registrant as Specified in its Charter) DELAWARE 39-1600938 (Sta

June 19, 2015 EX-3.3

CERTIFICATE OF AMENDMENT OF CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK MERGE HEALTHCARE INCORPORATED

EX-3.3 4 ex33.htm EXHIBIT 3.3 Exhibit 3.3 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK OF MERGE HEALTHCARE INCORPORATED Merge Healthcare Incorporated, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY: 1. The name of the Corporation is Merge Heal

June 19, 2015 EX-24

MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS

Exhibit 24 MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS KNOWN ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints JUSTIN C.

June 19, 2015 EX-3.1

CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION MERGE HEALTHCARE INCORPORATED

Exhibit 3.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF MERGE HEALTHCARE INCORPORATED MERGE HEALTHCARE INCORPORATED (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?DGCL?), does hereby certify as follows: 1. The name of the Corporation is Merge Healthcare Incorporated. 2. Pursuant to resolution of its Board o

June 19, 2015 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 19, 2015 (June 17, 2015) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001?33006 39-1600938 (State of incorporation) (Commission F

June 19, 2015 S-8 POS

Merge Tech MERGE HEALTHCARE INCORPORATED S-8 POS 6-19-2015 (333-189588)

As filed with the Securities and Exchange Commission on June 19, 2015. Registration No. 333-189588 Registration No. 333-175030 Registration No. 333-125386 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT No. 1 TO FORM S-8 Registration Statement Under The Securities Act of 1933 MERGE HEALTHCARE INCORPORATED (Exact name of Registrant as Specified in it

June 19, 2015 EX-3.4

MERGE HEALTHCARE INCORPORATED (a Delaware corporation) ARTICLE I. OFFICES

EX-3.4 5 ex34.htm EXHIBIT 3.4 Exhibit 3.4 BYLAWS OF MERGE HEALTHCARE INCORPORATED (a Delaware corporation) ARTICLE I. OFFICES 1.01. Principal and Business Offices. The corporation may have such principal and other business offices, either within or without the State of Delaware, as the Board of Directors may designate or as the business of the corporation may require from time to time. 1.02. Regis

June 19, 2015 S-8 POS

Merge Tech MERGE HEALTHCARE INCORPORATED S-8 POS 6-19-2015 (333-175030)

S-8 POS 1 forms8.htm MERGE HEALTHCARE INCORPORATED S-8 POS 6-19-2015 (333-175030) As filed with the Securities and Exchange Commission on June 19, 2015. Registration No. 333-189588 Registration No. 333-175030 Registration No. 333-125386 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT No. 1 TO FORM S-8 Registration Statement Under The Securities Act

June 19, 2015 S-8 POS

Merge Tech MERGE HEALTHCARE INCORPORATED S-8 POS 6-19-2015 (333-125386)

S-8 POS 1 forms8.htm MERGE HEALTHCARE INCORPORATED S-8 POS 6-19-2015 (333-125386) As filed with the Securities and Exchange Commission on June 19, 2015. Registration No. 333-189588 Registration No. 333-175030 Registration No. 333-125386 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT No. 1 TO FORM S-8 Registration Statement Under The Securities Act

June 19, 2015 EX-24

MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS

Exhibit 24 MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS KNOWN ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints JUSTIN C.

June 19, 2015 EX-24

MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS

EX-24 2 ex24.htm EXHIBIT 24 Exhibit 24 MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS KNOWN ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints JUSTIN C. DEARBORN, JARED GREEN and JULIE ANN B. SCHUMITSCH, their true and lawful attorney-in-fact and agent, with full power of substitution and resubstitu

June 19, 2015 EX-3.2

CERTIFICATE OF AMENDMENT OF CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK MERGE HEALTHCARE INCORPORATED

Exhibit 3.2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK OF MERGE HEALTHCARE INCORPORATED Merge Healthcare Incorporated, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY: 1. The name of the Corporation is Merge Healthcare Incorporated. 2. Pursua

May 29, 2015 CORRESP

Merge Tech ESP

May 29, 2015 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Gabriel Eckstein Re: Merge Healthcare Incorporated Registration Statement on Form S-4 (File No.

May 29, 2015 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 form8k.htm MERGE HEALTHCARE INC 8-K 5-29-2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 29, 2015 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938

May 29, 2015 EX-10.1

Exhibit 10.1

EX-10.1 2 ex101.htm EXHIBIT 10.1 Exhibit 10.1 May 29, 2015 Merrick Ventures, LLC 350 N. Orleans Street, 10th Floor Chicago, IL 60654 Attention: Mr. Michael W. Ferro, Jr. Re: Consulting Agreement Ladies and Gentlemen: Reference is made to the Consulting Agreement, dated as of January 1, 2009, by and between Merge Healthcare Incorporated, a Delaware corporation (the "Company"), and your affiliate, M

May 29, 2015 CORRESP

Merge Tech ESP

May 29, 2015 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Gabriel Eckstein Re: Merge Healthcare Incorporated Registration Statement on Form S-3 ( File No.

May 15, 2015 EX-24.1

MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-4 REGISTRATION STATEMENTS

Exhibit 24.1 MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-4 REGISTRATION STATEMENTS KNOWN ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of JUSTIN C. DEARBORN, JARED GREEN and JULIE ANN B. SCHUMITSCH their true and lawful attorney-in-fact and agent, each with full power of substitution and resubstitution, for them

May 15, 2015 S-4

Merge Tech MERGE HEALTHCARE INCORPORATED S-4 5-15-2015

As filed with the Securities and Exchange Commission on May 15, 2015 Registration No.

May 15, 2015 S-3

Merge Tech MERGE HEALTHCARE INCORPORATED S-3 5-15-2015

S-3 1 forms3.htm MERGE HEALTHCARE INCORPORATED S-3 5-15-2015 As filed with the Securities and Exchange Commission on May 15, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Merge Healthcare Incorporated (Exact Name of Registrant as Specified in Its Charter) Delaware 39-1600938 (State

May 15, 2015 EX-24.1

MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-3 REGISTRATION STATEMENTS

EX-24.1 5 ex241.htm EXHIBIT 24.1 Exhibit 24.1 MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-3 REGISTRATION STATEMENTS KNOWN ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of JUSTIN C. DEARBORN, JARED GREEN and JULIE ANN B. SCHUMITSCH their true and lawful attorney-in-fact and agent, each with full power of substitu

May 11, 2015 8-K/A

Merge Tech MERGE HEALTHCARE INCORPORATED 8-KA 2-25-2015 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 25, 2015 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001?33006 39-1600938 (State of incorporation) (Commi

May 11, 2015 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 11, 2015 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001?33006 39-1600938 (State of incorporation) (Commission File Number) (I.R.

May 11, 2015 EX-99.2

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share data)

Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share data) The following unaudited pro forma condensed consolidated financial statements are based upon the historical financial statements of Merge Healthcare Incorporated (?Merge,? ?we,? ?us? or ?our?) and D.R. Systems, Inc. (?DR Systems?) after giving effect to our acquisition of 91.5% of the iss

May 11, 2015 EX-99.1

Common Stock

Exhibit 99.1 DR Systems, Inc. Financial Statements Years Ended December 31, 2014 and 2013 DR Systems, Inc. Contents Independent Auditors? Report 3-4 Financial Statements Balance Sheets 5 Statements of Income 6 Statements of Stockholders? Equity 7 Statements of Cash Flows 8 Notes to Financial Statements 9-17 Independent Auditors? Report To the Board of Directors and Stockholders of DR Systems, Inc.

May 11, 2015 EX-99.1

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share data)

Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share data) The following unaudited pro forma condensed consolidated financial statement is based upon the historical financial statements of Merge Healthcare Incorporated (?Merge,? ?we,? ?us? or ?our?) and D.R. Systems, Inc. (?DR Systems?) after giving effect to our acquisition of 91.5% of the issue

May 8, 2015 DEFA14A

Merge Tech MERGE HEALTHCARE DEFA 14A 6-17-2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

May 8, 2015 DEF 14A

Merge Tech MERGE HEALTHCARE INCORPORATED DEF 14A 6-17-2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

April 28, 2015 PRE 14A

Merge Tech MERGE HEALTHCARE INC PRE 14A 6-17-2015

PRE 14A 1 formpre14a.htm MERGE HEALTHCARE INC PRE 14A 6-17-2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission

April 28, 2015 EX-99.1

MERGE REPORTS FIRST QUARTER FINANCIAL RESULTS Increases healthcare segment sales bookings by 60% YOY

Exhibit 99.1 News Release Media Contact: Michael Klozotsky Vice President, Corporate Marketing 312.946.2535 [email protected] MERGE REPORTS FIRST QUARTER FINANCIAL RESULTS Increases healthcare segment sales bookings by 60% YOY Chicago, IL (April 28, 2015) ? Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of health information systems for medical imaging, interoperability

April 28, 2015 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 28, 2015 (April 22, 2015) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001?33006 39-1600938 (State of incorporation) (Commission File Number) (I.

March 9, 2015 SC 13D

METI / Merge Tech Inc / GUGGENHEIM CAPITAL LLC Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Merge Healthcare Incorporated (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 589499102 (CUSIP Number) Robert Saperstein 330 Madison Avenue New York, NY 10017 (212) 901-9402 (Name, Address and Telephone Number of Person Authorized to

March 3, 2015 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 3, 2015 (February 25, 2015) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

March 3, 2015 EX-10.1

Exhibit 10.1

EX-10.1 2 ex101.htm EXHIBIT 10.1 Exhibit 10.1 STOCK PURCHASE AGREEMENT among THE SELLERS LISTED ON THE SIGNATURE PAGE HERETO and MERGE HEALTHCARE SOLUTIONS INC. and CHARLES ZUCKERMAN (AS THE SELLERS’ REPRESENTATIVE) dated as of FEBRUARY 25, 2015 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this “Agreement”), dated as of February 25, 2015, is entered into between persons listed on the si

March 3, 2015 EX-10.5

Exhibit 10.5

Exhibit 10.5 INVESTOR RIGHTS AGREEMENT dated as of February 25, 2015 by and between MERGE HEALTHCARE INCORPORATED and the INVESTORS Listed on SCHEDULE 1 Hereto Table of Contents Page ARTICLE I DEFINITIONS 1 SECTION 1.1. Definitions 1 SECTION 1.2. General Interpretive Principles 5 ARTICLE II REGISTRATION RIGHTS 5 SECTION 2.1. Demand Registration 5 SECTION 2.2. Piggyback Registration 8 SECTION 2.3.

March 3, 2015 EX-10.2

Exhibit 10.2

Exhibit 10.2 PURCHASE AGREEMENT dated as of February 25, 2015 by and between MERGE HEALTHCARE INCORPORATED and the INVESTORS Party Hereto TABLE OF CONTENTS Page ARTICLE I PURCHASE AND SALE OF THE SERIES A PREFERRED STOCK 1 1.1 Purchase and Sale of the Series A Preferred Stock 1 1.2 The Closing 2 1.3 Deliveries at the Closing 2 ARTICLE II REPRESENTATIONS AND WARRANTIES OF THE COMPANY 3 2.1 Organiza

March 3, 2015 EX-10.3

Exhibit 10.3

EX-10.3 4 ex103.htm EXHIBIT 10.3 Exhibit 10.3 Execution Copy WAIVER AND FIRST AMENDMENT TO CREDIT AGREEMENT This WAIVER AND FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of February 25, 2015, is among MERGE HEALTHCARE INCORPORATED, a Delaware limited liability company (the “Borrower”), each of the undersigned subsidiaries of the Borrower (each, a “Subsidiary Guarantor” and colle

March 3, 2015 EX-10.4

Exhibit 10.4

Exhibit 10.4 CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK OF MERGE HEALTHCARE INCORPORATED Pursuant to Section 151 of the General Corporation Law of the State of Delaware MERGE HEALTHCARE INCORPORATED (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), certifies that, pursuant to authority conferre

February 26, 2015 EX-99.1

MERGE REPORTS FOURTH QUARTER FINANCIAL RESULTS AND ANNOUNCES THE ACQUISITION OF DR SYSTEMS, INC. Delivers GAAP net income and increased adjusted EBITDA by 35% YOY Annual adjusted EBITDA guidance exceeded

EX-99.1 2 ex991.htm EXHIBIT 99.1 News Release Media Contact: Michael Klozotsky Vice President of Marketing 312.946.2535 [email protected] Exhibit 99.1 MERGE REPORTS FOURTH QUARTER FINANCIAL RESULTS AND ANNOUNCES THE ACQUISITION OF DR SYSTEMS, INC. Delivers GAAP net income and increased adjusted EBITDA by 35% YOY Annual adjusted EBITDA guidance exceeded Chicago, IL (February 25, 2015) – M

February 26, 2015 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 25, 2015 (February 25, 2015) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

December 4, 2014 CORRESP

METI / Merge Tech Inc CORRESP - -

www.merge.com December 4, 2014 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Patrick Gilmore Accounting Branch Chief Re: Merge Healthcare Incorporated Form 10-K for the Fiscal Year Ended December 31, 2013 Filed March 14, 2014 Form 10-Q for the Quarterly Period Ended September 30, 2014 Filed October 29, 201

November 24, 2014 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 24, 2014 (November 21, 2014) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

October 29, 2014 EX-99.1

MERGE REPORTS THIRD QUARTER FINANCIAL RESULTS Company delivers GAAP net income and doubles prior year adjusted EBITDA Also reports sequential growth in quarterly revenue and adjusted EBITDA

Exhibit 99.1 News Release Media Contact: Steven Tolle Chief Strategy Officer 312.946.2503 [email protected] MERGE REPORTS THIRD QUARTER FINANCIAL RESULTS Company delivers GAAP net income and doubles prior year adjusted EBITDA Also reports sequential growth in quarterly revenue and adjusted EBITDA Chicago, IL (October 29, 2014) – Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider

October 29, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 29, 2014 (October 29, 2014) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

July 30, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 30, 2014 (July 30, 2014) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

July 30, 2014 EX-99.1

MERGE REPORTS SECOND QUARTER FINANCIAL RESULTS Company reports sequential revenue and adjusted EBITDA growth

EX-99.1 2 ex991.htm EXHIBIT 99.1 Exhibit 99.1 News Release Media Contact: Jennifer Jawor Vice President, Corporate Marketing 312.565.6825 [email protected] MERGE REPORTS SECOND QUARTER FINANCIAL RESULTS Company reports sequential revenue and adjusted EBITDA growth Chicago, IL (July 30, 2014) – Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of innovative enterprise imaging,

June 20, 2014 S-8

- MERGE HEALTHCARE INCORPORATED S-8 6-20-2014

As filed with the Securities and Exchange Commission on June 20, 2014. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 Registration Statement Under The Securities Act of 1933 MERGE HEALTHCARE INCORPORATED (Exact name of Registrant as Specified in its Charter) DELAWARE 39-1600938 (State or other jurisdiction of incorporation or organization) (I

June 20, 2014 EX-24

MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS

EX-24 4 ex24.htm EXHIBIT 24 Exhibit 24 MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS KNOWN ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints JUSTIN C. DEARBORN, JARED GREEN and JULIE ANN B. SCHUMITSCH, their true and lawful attorney-in-fact and agent, with full power of substitution and resubstitu

June 19, 2014 8-K

Submission of Matters to a Vote of Security Holders - MERGE HEALTHCARE INCORPORATED 8-K 6-16-2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 16, 2014 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

May 5, 2014 8-K

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement - MERGE HEALTHCARE INCORPORATED 8-K 4-29-2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 5, 2014 (April 29, 2014) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

May 5, 2014 EX-10.2

Exhibit 10.2

Exhibit 10.2 SECURITY AGREEMENT dated as of April 29, 2014, among MERGE HEALTHCARE INCORPORATED, as Borrower, and THE SUBSIDIARY GUARANTORS PARTY HERETO, and GUGGENHEIM CORPORATE FUNDING, LLC, as Collateral Agent TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INTERPRETATION 1 SECTION 1.1 Definitions 1 SECTION 1.2 Perfection Certificate 8 ARTICLE II GRANT OF SECURITY AND SECURED OBLIGATIONS 8 SEC

May 5, 2014 EX-10.1

Exhibit 10.1

EX-10.1 2 ex101.htm EXHIBIT 10.1 Exhibit 10.1 EXECUTION VERSION CREDIT AGREEMENT dated as of April 29, 2014, among MERGE HEALTHCARE INCORPORATED, as Borrower, and THE SUBSIDIARY GUARANTORS PARTY HERETO, as Subsidiary Guarantors, THE LENDERS PARTY HERETO and GUGGENHEIM CORPORATE FUNDING, LLC, as Lead Arranger and Book Runner, and GUGGENHEIM CORPORATE FUNDING, LLC, as Administrative Agent and Collat

April 30, 2014 EX-99.1

MERGE REPORTS FIRST QUARTER FINANCIAL RESULTS Company reports strong cash flow, overall profitability, growth in adjusted EBITDA and debt refinancing

Exhibit 99.1 News Release Media Contact: Jennifer Jawor Vice President, Corporate Marketing 312.565.6825 [email protected] MERGE REPORTS FIRST QUARTER FINANCIAL RESULTS Company reports strong cash flow, overall profitability, growth in adjusted EBITDA and debt refinancing Chicago, IL (April 30, 2014) – Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of innovative enterprise

April 30, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 30, 2014 (April 30, 2014) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

April 29, 2014 DEFR14A

- MERGE HEALTHCARE INCORPORATED DEFR 14A 6-16-2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)

April 28, 2014 DEFA14A

- MERGE HEALTHCARE INCORPORATED DEFA 14A 6-16-2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

April 28, 2014 DEF 14A

- MERGE HEALTHCARE INCORPORATED DEF 14A 6-16-2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)

March 17, 2014 10-K/A

Merge Tech MERGE HEALTHCARE INCORPORATED 10-KA 12-31-2013 (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33006 MERGE HEALT

February 20, 2014 EX-99.1

MERGE REPORTS FOURTH QUARTER FINANCIAL RESULTS Merge builds momentum with significantly improved operating results, cash flow generation and launch of new advanced interoperability service in quarter

Exhibit 99.1 News Release Media Contact: Jennifer Jawor Vice President, Corporate Marketing 312.565.6825 [email protected] MERGE REPORTS FOURTH QUARTER FINANCIAL RESULTS Merge builds momentum with significantly improved operating results, cash flow generation and launch of new advanced interoperability service in quarter Chicago, IL (February 20, 2014) – Merge Healthcare Incorporated (NASDA

February 20, 2014 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2014 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 39-1600938 (State or Other Jurisdiction of Incorporation or Organizatio

February 20, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 20, 2014 (February 20, 2014) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

February 11, 2014 SC 13G/A

METI / Merge Tech Inc / NORTHPOINTE CAPITAL LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Merge Healthcare Incorporated (Name of Issuer) Common Stock (Title of Class of Securities) 589499102 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic

January 8, 2014 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 8, 2014 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

January 8, 2014 EX-99.1

MERGE REVISES PREVIOUSLY-ANNOUNCED SUBSCRIPTION BACKLOG TOTALS No Impact on Historical Financial Results eClinical Business Unit Continues Strong Growth

EXHIBIT 99.1 News Release Media Contact: Jennifer Jawor Director, Corporate Marketing 312.565.6825 | [email protected] MERGE REVISES PREVIOUSLY-ANNOUNCED SUBSCRIPTION BACKLOG TOTALS No Impact on Historical Financial Results eClinical Business Unit Continues Strong Growth Chicago, IL (January 8, 2014). Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and i

October 30, 2013 EX-99.1

MERGE REPORTS THIRD QUARTER FINANCIAL RESULTS Merge generates record cash from business operations in quarter

EX-99.1 2 ex991.htm EXHIBIT 99.1 Exhibit 99.1 News Release Media Contact: Jennifer Jawor Director, Corporate Marketing 312.565.6825 | [email protected] MERGE REPORTS THIRD QUARTER FINANCIAL RESULTS Merge generates record cash from business operations in quarter Chicago, IL (October 30, 2013) Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations

October 30, 2013 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - MERGE HEALTHCARE INCORPORATED 8-K 10-30-2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 30, 2013 (October 30, 2013) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

September 4, 2013 SC 13D/A

METI / Merge Tech Inc / FERRO MICHAEL W JR - MICHAEL W. FERRO, JR SC 13D A NO 11 8-26-2013 (MERGE HEALTHCARE) Activist Investment

RUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 11) Merge Healthcare Incorporated (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Secu

August 27, 2013 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - MERGE HEALTHCARE INCORPORATED 8-K 8-26-2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 26, 2013 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

August 9, 2013 EX-10.1

Merge Healthcare Attention: Alan Thornberry 900 Walnut Ridge Drive Hartland, WI 53029

Exhibit 10.1 August 7, 2013 Jeffery A. Surges Dear Jeff: This letter is written to confirm our agreement regarding the separation of your employment with Merge Healthcare Incorporated (“Merge Healthcare” or the “Company”). You agree that your last day of employment with Merge Healthcare will be August 8, 2013. You will receive your final regular pay check on the Company’s next payroll date after A

August 9, 2013 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - MERGE HEALTHCARE INCORPORATED 8-K 8-5-2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 9, 2013 (August 5, 2013) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

August 9, 2013 EX-99.1

MERGE REPORTS SECOND QUARTER FINANCIAL RESULTS

EX-99.1 2 ex991.htm EXHIBIT 99.1 Exhibit 99.1 News Release Media Contact: Lesley Weisenbacher Vice President, Marketing 312.540.6623 | [email protected] MERGE REPORTS SECOND QUARTER FINANCIAL RESULTS Merge announces the resignation of Jeffery Surges and the appointment of Justin Dearborn as CEO Chicago, IL (Aug. 9, 2013) Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider

August 9, 2013 EX-10.2

MERGE HEALTHCARE INCORPORATED GENERAL RELEASE

EX-10.2 3 ex102.htm EXHIBIT 10.2 Exhibit 10.2 MERGE HEALTHCARE INCORPORATED GENERAL RELEASE 1. General Release of Claims. I hereby release the Company, as defined herein from, and covenant not to sue the Company with respect to, any and all claims I have or may have against the Company. 2. Claims to Which Release Applies. This release applies both to claims that are now known or are later discover

August 9, 2013 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - MERGE HEALTHCARE INC 8-K 8-9-2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 9, 2013 (August 9, 2013) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

June 25, 2013 EX-24

MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS

EXHIBIT 24 MERGE HEALTHCARE INCORPORATED POWER OF ATTORNEY REGARDING CERTAIN FORM S-8 REGISTRATION STATEMENTS KNOWN ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints JUSTIN C.

June 25, 2013 S-8

- MERGE HEALTHCARE INCORPORATED S-8 6-25-2013

As filed with the Securities and Exchange Commission on June 25, 2013. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 Registration Statement Under The Securities Act of 1933 MERGE HEALTHCARE INCORPORATED (Exact name of Registrant as Specified in its Charter) DELAWARE 39-1600938 (State or other jurisdiction of incorporation or organization) (I

June 24, 2013 8-K

Submission of Matters to a Vote of Security Holders - MERGE HEALTHCARE INC 8-K 6-18-2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2013 MERGE HEALTHCARE INCORPORATED (Exact name of Registrant as specified in its charter) Delaware 001–33006 39-1600938 (State or other jurisdiction of incorporation) (Commis

June 21, 2013 EX-1.0

Exhibit 1

Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their behalf with respect to the beneficial ownership of any equity securities of Merge Healthcare Incorporated, or any subsequent acquisitions or dispositions of equity securities of Merge Healthcare Incorporated by any of the undersigned.

June 21, 2013 SC 13D/A

METI / Merge Tech Inc / Merrick Venture Management Holdings, Llc - MERRICK VENTURE MANAGEMENT HOLDINGS, LLC SC 13DA 6-18-2013 (MERGE HEALTHCARE INCORPORATED) Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 10) Merge Healthcare Incorporated (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Secur

May 20, 2013 EX-10.2

MERGE HEALTHCARE INCORPORATED GENERAL RELEASE

Exhibit 10.2 MERGE HEALTHCARE INCORPORATED GENERAL RELEASE 1. General Release of Claims. I hereby release the Company, as defined herein from, and covenant not to sue the Company with respect to, any and all claims I have or may have against the Company. 2. Claims to Which Release Applies. This release applies both to claims that are now known or are later discovered. However, this release does no

May 20, 2013 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - MERGE HEALTHCARE INCORPORATED 8-K 5-14-2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 20, 2013 (May 14, 2013) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

May 20, 2013 EX-10.1

200 E. Randolph Street, 24th Floor | Chicago, IL 60601 | P: 312.540.6648 | F: 312.565.6870

May 17, 2013 Exhibit 10.1 Ann Mayberry-French 730 S. Clark St., Apt. 2208 Chicago, IL 60605 Dear Ann: This letter is written to confirm our conversation regarding the separation of your employment with Merge Healthcare Incorporated (“Merge Healthcare”). Your last day of employment with Merge Healthcare was May 14, 2013. You will receive your final regular pay check on 5/31/2013. This pay check wil

May 14, 2013 DEFA14A

- MERGE HEALTHCARE INCORPORATED DEFA14A 5-14-2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)

May 6, 2013 EX-99.2

05/02/13 Page 1 of 13

Exhibit 99.2 Speaker 1: Well, thank you operator and thanks to everyone for joining us this morning for an update on our solid Q1 performance. As we typically structure this call, I will provide an update on the overall organization, as well as the Merge Healthcare operating group. And Justin Dearborn will provide an update on the Merge DNA side of our business. S1: Let me start with the fact that

May 6, 2013 EX-99.1

MERGE REPORTS RECORD FIRST QUARTER SALES

Exhibit 99.1 News Release Media Contact: Lesley Weisenbacher Vice President, Marketing 312.540.6623 | [email protected] MERGE REPORTS RECORD FIRST QUARTER SALES Successfully Refinances Existing Debt at Half the Interest Rate Chicago, IL (May 1, 2013) Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, t

May 6, 2013 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - MERGE HEALTHCARE INC 8-K 4-30-2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2013 (April 30, 2013) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

April 30, 2013 DEFA14A

- DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule

April 30, 2013 DEF 14A

- DEF 14A

DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule

April 29, 2013 EX-10.1

CREDIT AGREEMENT dated as of April 23, 2013, MERGE HEALTHCARE INCORPORATED, as Borrower, THE SUBSIDIARY GUARANTORS PARTY HERETO, as Subsidiary Guarantors, THE LENDERS PARTY HERETO JEFFERIES FINANCE LLC, as Lead Arranger and Book Runner, BANK OF AMERI

EX-10.1 Exhibit 10.1 EXECUTION VERSION CREDIT AGREEMENT dated as of April 23, 2013, among MERGE HEALTHCARE INCORPORATED, as Borrower, and THE SUBSIDIARY GUARANTORS PARTY HERETO, as Subsidiary Guarantors, THE LENDERS PARTY HERETO and JEFFERIES FINANCE LLC, as Lead Arranger and Book Runner, and BANK OF AMERICA, N.A., as Documentation Agent and JEFFERIES FINANCE LLC, as Administrative Agent and Colla

April 29, 2013 EX-10.2

SECURITY AGREEMENT dated as of April 23, 2013, MERGE HEALTHCARE INCORPORATED, as Borrower, THE SUBSIDIARY GUARANTORS PARTY HERETO, JEFFERIES FINANCE LLC, as Collateral Agent TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INTERPRETATION SECTION 1.1

EX-10.2 Exhibit 10.2 EXECUTION VERSION SECURITY AGREEMENT dated as of April 23, 2013, among MERGE HEALTHCARE INCORPORATED, as Borrower, and THE SUBSIDIARY GUARANTORS PARTY HERETO, and JEFFERIES FINANCE LLC, as Collateral Agent TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INTERPRETATION SECTION 1.1 Definitions 1 SECTION 1.2 Perfection Certificate 8 ARTICLE II GRANT OF SECURITY AND SECURED OBLIG

April 29, 2013 8-K

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 29, 2013 (April 23, 2013) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

April 22, 2013 8-K

- FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 22, 2013 (April 16, 2013) Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporation) (Commission File Number) (I.

April 22, 2013 EX-4.1

FOURTH SUPPLEMENTAL INDENTURE April 16, 2013 BY AND BETWEEN MERGE HEALTHCARE INCORPORATED, THE GUARANTORS NAMED ON THE SIGNATURE PAGES HERETO THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS TRUSTEE AND COLLATERAL AGENT, 11.75% SENIOR SECURED NOTE

EX-4.1 EXHIBIT 4.1 FOURTH SUPPLEMENTAL INDENTURE April 16, 2013 BY AND BETWEEN MERGE HEALTHCARE INCORPORATED, THE GUARANTORS NAMED ON THE SIGNATURE PAGES HERETO AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS TRUSTEE AND COLLATERAL AGENT, 11.75% SENIOR SECURED NOTES DUE 2015 FOURTH SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of April 16, 2013, by and between Merge Heal

April 3, 2013 EX-1

Exhibit 1

Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their behalf with respect to the beneficial ownership of any equity securities of Merge Healthcare Incorporated, or any subsequent acquisitions or dispositions of equity securities of Merge Healthcare Incorporated by any of the undersigned.

April 3, 2013 EX-99.1

MERGE HEALTHCARE ANNOUNCES TENDER OFFER AND CONSENT SOLICITATION FOR 11.75% SENIOR SECURED NOTES DUE 2015

EX-99.1 Exhibit 99.1 News Release Media Contact: Lesley Weisenbacher Vice President, Marketing 312.540.6623 | [email protected] MERGE HEALTHCARE ANNOUNCES TENDER OFFER AND CONSENT SOLICITATION FOR 11.75% SENIOR SECURED NOTES DUE 2015 Chicago, IL (April 2, 2013) Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform he

April 3, 2013 8-K

Current Report

8-K 1 d514897d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 2, 2013 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State of incorporati

April 3, 2013 SC 13D/A

METI / Merge Tech Inc / Merrick Venture Management Holdings, Llc - MERRICK VENTURE MANAGEMENT HOLDINGS LLC SC 13D A 3-14-2013 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 9) Merge Healthcare Incorporated (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securi

February 21, 2013 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - MERGE HEALTHCARE INC 8-K 2-19-2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 19, 2013 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State or Other Jurisdiction of (Commission File (

February 21, 2013 EX-99.1

MERGE REPORTS SUBSCRIPTION BACKLOG UP 82%

EXHIBIT 99.1 News Release Media Contact: Lesley Weisenbacher Vice President, Marketing 312.540.6623 | [email protected] MERGE REPORTS SUBSCRIPTION BACKLOG UP 82% Delivers fourth quarter sales of $65.1 million and reiterates 2013 guidance of sales range of $265 - $275 million Chicago, IL (Feb. 19, 2013) Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems

February 21, 2013 EX-99.2

MergeQ4Earnings

EXHIBIT 99.2 MergeQ4Earnings Speaker 1: And thanks to all of you for joining us this morning. I'm pleased to have the opportunity to share our 2012 Q4 record results as well as an update on the company's market outlook and our strategies for 2013. Before I begin this discussion, I want to first address the announcement we made in September of 2012. As you'll recall, at that time, we stated that ou

February 11, 2013 SC 13G/A

METI / Merge Tech Inc / NORTHPOINTE CAPITAL LLC - NORTHPOINTE CAPITAL LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Merge Healthcare Incorporated (Name of Issuer) Common Stock (Title of Class of Securities) 589499102 (CUSIP Number) December 31, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic

December 31, 2012 EX-99.1

Exhibit 1

Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D (or any amendment thereof) need be filed on their behalf with respect to the beneficial ownership of any equity securities of Merge Healthcare Incorporated, or any subsequent acquisitions or dispositions of equity securities of Merge Healthcare Incorporated by any of the undersigned.

December 31, 2012 SC 13D/A

METI / Merge Tech Inc / Merrick RIS, LLC - MERGE HEALTHCARE SC 13D/A #8 12-20-2012 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 8) Merge Healthcare Incorporated (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securi

November 6, 2012 EX-99.2

MERGE HEALTHCARE INCORPORATED November 1, 2012 8:30 a.m. ET

EX-99.2 4 m82984x992103112.htm TRANSCRIPT MERGE HEALTHCARE INCORPORATED Transcript November 1, 2012 8:30 a.m. ET MOD: Good morning and welcome to Merge’s third quarter 2012 earnings call. Today’s call is being hosted by Jeff Surges, Chief Executive Officer; Justin Dearborn, President; and Steve Oreskovich, Merge’s Chief Financial Officer. Before we get started, please consider that the comments to

November 6, 2012 EX-99.1

CORRECTING and REPLACING -- MERGE REPORTS 2012 SUBSCRIPTION BACKLOG UP 62%

News Release Media Contact: Lesley Weisenbacher Vice President, Marketing 312.540.6623 | [email protected] CORRECTING and REPLACING - MERGE REPORTS 2012 SUBSCRIPTION BACKLOG UP 62% Delivers third quarter revenue of $61 million and announces 2013 guidance of pro forma revenue range of $265 - $275 million Chicago, IL (Oct. 31, 2012) In a press release issued earlier today by Merge Health

November 6, 2012 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - OCTOBER 31, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 31, 2012 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State or Other Jurisdiction of (Commission File (I

September 12, 2012 SC 13D/A

METI / Merge Tech Inc / Merrick RIS, LLC - AMENDMENT NO. 7 Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities and Exchange Act of 1934 (Amendment No. 7) MERGE HEALTHCARE INCORPORATED (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 589499102 (CUSIP Number) Merrick RIS, LLC 350 North Orleans Street 10th Floor Chicago, Illinois 60654 (312) 994-9435 with a copy to: Mark A. Harris

September 6, 2012 EX-99.1

MERGE ENGAGES ALLEN & COMPANY LLC TO EXPLORE AND EVALUATE STRATEGIC ALTERNATIVES

News Release Media Contact: Steve Oreskovich Chief Financial Officer (262) 912-3412 steve.

September 6, 2012 8-K

Financial Statements and Exhibits, Other Events - SEPTEMBER 6, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 6, 2012 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 39-1600938 (State or Other Jurisdiction of (I.R.S. Employer Incorporati

August 20, 2012 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - AUGUST 15, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 15, 2012 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 39-1600938 (State or Other Jurisdiction of (I.R.S. Employer Incorporation

August 1, 2012 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - MERGE HEALTHCARE INCORPORATED 8-K 7-31-2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 31, 2012 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State or Other Jurisdiction of (Commission File (I.R.

August 1, 2012 EX-99.1

MERGE REPORTS SECOND QUARTER SALES GROWTH OF 13% Signs new clients under subscription model and is named #1 VNA in the world

Exhibit 99.1 News Release Media Contact: Lesley Weisenbacher Vice President, Marketing 312.540.6623 | [email protected] MERGE REPORTS SECOND QUARTER SALES GROWTH OF 13% Signs new clients under subscription model and is named #1 VNA in the world Chicago, IL (July 31, 2012) Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to t

July 2, 2012 CORRESP

-

Boston Brussels Chicago Düsseldorf Houston London Los Angeles Miami Milan Munich New York Orange County Paris Rome Silicon Valley Washington, D.

June 20, 2012 8-K

Submission of Matters to a Vote of Security Holders - JUNE 18, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2012 MERGE HEALTHCARE INCORPORATED (Exact name of Registrant as specified in its charter) Delaware 001–33006 39-1600938 (State or other jurisdiction of incorporation) (Commis

June 6, 2012 CORRESP

-

Confidential Treatment Requested by Merge Healthcare Incorporated Boston Brussels Chicago Düsseldorf Houston London Los Angeles Miami Milan Munich New York Orange County Paris Rome Silicon Valley Washington, D.

May 16, 2012 SC 13D/A

METI / Merge Tech Inc / MERGE HEALTHCARE INC - AMENDMENT NO. 7 Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities and Exchange Act of 1934 (Amendment No. 7)* MERGE HEALTHCARE INCORPORATED (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 589499102 (CUSIP Number) Merrick RIS, LLC 350 North Orleans Street 10th Floor Chicago, Illinois 60654 (312) 994-9410 with a copy to: Mark A. Harri

May 8, 2012 EX-99.1

MERGE CREATES TWO OPERATING GROUPS TO ALIGN TO MARKET TRENDS AND REPORTS FIRST QUARTER RESULTS OF OPERATIONS Drives 16% year-over-year revenue growth and moves to subscription model

News Release FOR IMMEDIATE RELEASE Media Contact: Brenda Stewart Director, Marketing Communications 312.

May 8, 2012 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition - MAY 7, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2012 Merge Healthcare Incorporated (Exact name of registrant as specified in its charter) Delaware 39-1600938 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or

April 30, 2012 DEF 14A

- MERGE HEALTHCARE INC DEF 14A 6-18-2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Defin

April 30, 2012 DEFA14A

- MERGE HEALTHCARE INC DEFA14A 4-30-2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin

April 3, 2012 8-K

Entry into a Material Definitive Agreement - MARCH 28, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2012 MERGE HEALTHCARE INCORPORATED (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State or other jurisdiction of incorporation) (Commi

February 16, 2012 EX-99.1

MERGE HEALTHCARE SETS RECORD PRO FORMA SALES OF $65.1M IN FOURTH QUARTER Achieves full year 2011 revenue and EBITDA plan

News Release FOR IMMEDIATE RELEASE Media Contact: Brenda Stewart Director, Marketing Communications 773.

February 16, 2012 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2012 MERGE HEALTHCARE INCORPORATED (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State or other jurisdiction of incorporation) (Co

February 10, 2012 SC 13G/A

METI / Merge Tech Inc / NORTHPOINTE CAPITAL LLC - NORTHPOINTE CAPITAL LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Merge Healthcare Incorporated (Name of Issuer) Common Stock (Title of Class of Securities) 589499102 (CUSIP Number) December 31, 2011 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic

January 10, 2012 SC 13G/A

METI / Merge Tech Inc / GILDER GAGNON HOWE & CO LLC - SCHEDULE 13G FINAL AMENDMENT Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2. Under the Securities Exchange Act of 1934 Final Amendment Merge Healthcare Incorporated (Name of Issuer) Common Stock (Title of Class of Securities) 589499102 (CUSIP Number)

January 5, 2012 8-K

Entry into a Material Definitive Agreement - DECEMBER 3, 2011

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2011 MERGE HEALTHCARE INCORPORATED (Exact name of registrant as specified in its charter) Delaware 001–33006 39-1600938 (State or other jurisdiction of incorporation) (Co

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista